In statement, Jim Greenwood, BIO's President and CEO, said we applaud President Obama's announcement of a new Precision Medicine Initiative intended to better embrace the potential of precision medicine, which would advance a new approach to healthcare by tailoring therapies for patients to maximize clinical benefit while reducing risk of side effects. Precision medicine holds great promise for many health care interventions to occur much earlier and with increased accuracy.